HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Korean family with a dominantly inherited beta-thalassemia due to Hb Durham-N.C./Brescia.

Abstract
We describe the molecular and the hematological characteristics of a Korean family with a dominantly inherited beta-thalassemia. Carriers were characterized by moderate anemia, hypochromia, microcytosis, elevated Hb A2 and Hb F levels, and splenomegaly. DNA analysis revealed a CTG (Leu) to CCG (Pro) substitution at codon 114 of the beta-globin gene, that leads to a highly unstable hemoglobin variant, Hb Durham-N.C./Brescia, and this was linked to the beta haplotype V, [+----+-], and framework 2. RNA analysis showed that the proband had comparable levels of mutant and normal beta-mRNA. Translation of the mutant mRNA would give rise to non-functional hyperunstable beta-globin chains, and their degradation would, by placing an additional burden on the proteolytic process of the red blood cell precursors, result in a more severe phenotype.
AuthorsJ Y Kim, S S Park, S H Yang, S I Joo, Y J Lee, E K Ra, S Shin, E C Kim, H I Cho
JournalHemoglobin (Hemoglobin) Vol. 25 Issue 1 Pg. 79-89 (Feb 2001) ISSN: 0363-0269 [Print] England
PMID11300352 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Codon
  • Hemoglobins, Abnormal
  • RNA, Messenger
  • hemoglobin Brescia
  • Globins
Topics
  • Adolescent
  • Adult
  • Amino Acid Substitution
  • Codon (genetics)
  • DNA Mutational Analysis
  • Female
  • Genes, Dominant
  • Globins (genetics)
  • Haplotypes (genetics)
  • Hemoglobins, Abnormal (analysis, genetics)
  • Heterozygote
  • Humans
  • Korea (epidemiology)
  • Male
  • Middle Aged
  • Mutation, Missense
  • Phenotype
  • Protein Biosynthesis
  • RNA, Messenger (biosynthesis)
  • Splenomegaly (etiology)
  • beta-Thalassemia (epidemiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: